Stepanenko A, Sosnovtseva A, Valikhov M, Chernysheva A, Cherepanov S, Yusubalieva G, et al. Superior infectivity of the fiber chimeric oncolytic adenoviruses Ad5/35 and Ad5/3 over Ad5-delta-24-RGD in primary glioma cultures. Mol Ther Oncolytics. 2022;24:230-248 pubmed publisher

Morales Molina Á, Rodríguez Milla M, Gimenez Sanchez A, Perisé Barrios A, Garcia Castro J. Cellular Virotherapy Increases Tumor-Infiltrating Lymphocytes (TIL) and Decreases their PD-1+ Subsets in Mouse Immunocompetent Models. Cancers (Basel). 2020;12: pubmed publisher

Mun K, Punga T. Cellular Zinc Finger Protein 622 Hinders Human Adenovirus Lytic Growth and Limits Binding of the Viral pVII Protein to Virus DNA. J Virol. 2019;93: pubmed publisher

Hoti N, Johnson T, Chowdhury W, Rodriguez R. Loss of Cyclin-Dependent Kinase Inhibitor Alters Oncolytic Adenovirus Replication and Promotes More Efficient Virus Production. Cancers (Basel). 2018;10: pubmed publisher

Frost J, Mendez M, Soriano A, Crisostomo L, Olanubi O, Radko S, et al. Adenovirus 5 E1A-Mediated Suppression of p53 via FUBP1. J Virol. 2018;92: pubmed publisher

Olanubi O, Frost J, Radko S, Pelka P. Suppression of Type I Interferon Signaling by E1A via RuvBL1/Pontin. J Virol. 2017;91: pubmed publisher

Tufail Y, Cook D, Fourgeaud L, Powers C, Merten K, Clark C, et al. Phosphatidylserine Exposure Controls Viral Innate Immune Responses by Microglia. Neuron. 2017;93:574-586.e8 pubmed publisher

Jung R, Radko S, Pelka P. The Dual Nature of Nek9 in Adenovirus Replication. J Virol. 2016;90:1931-43 pubmed publisher